{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T01:30:20Z","timestamp":1789781420204,"version":"4.0.1"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.radonc.2025.111107","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T06:15:00Z","timestamp":1755497700000},"page":"111107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Definition and requirements for stereotactic radiotherapy: a systematic review"],"prefix":"10.1016","volume":"211","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3568-269X","authenticated-orcid":false,"given":"\u0141ukasz","family":"Kuncman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina De","family":"la Pinta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1200-640X","authenticated-orcid":false,"given":"Maaike T.W.","family":"Milder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8332-1680","authenticated-orcid":false,"given":"Alejandra M\u00e9nd\u00e8z","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7146-9071","authenticated-orcid":false,"given":"Matthias","family":"Guckenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Franzese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0320-559X","authenticated-orcid":false,"given":"Marta","family":"Scorsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogumi\u0142a","family":"Bruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0734-6464","authenticated-orcid":false,"given":"Dirk","family":"Verellen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Tanadini-Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.111107_b0005","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.8006","article-title":"Long-term outcomes of stereotactic body radiotherapy for low-risk and intermediate-risk prostate cancer","volume":"2","author":"Kishan","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.radonc.2025.111107_b0010","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S1470-2045(19)30569-8","article-title":"Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial","volume":"20","author":"Brand","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0015","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jama.2016.9839","article-title":"Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial","volume":"316","author":"Brown","year":"2016","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.radonc.2025.111107_b0020","doi-asserted-by":"crossref","unstructured":"Das IJ, Dawes SL, Dominello MM, Kavanagh B, Miyamoto CT, Pa Wenn Sie \u00dcberschriften hinzuf\u00fcgen und sie als \u00dcberschriften formatieren (\u201eFormat\u201c > \u201eAbsatzstile\u201c), werden sie automatisch ins Inhaltsverzeichnis aufgenommen. wlicki T, Santanam L, Vinogradskiy Y, Yeung AR. Quality and Safety Considerations in Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy: An ASTRO Safety White Paper Update. Pract Radiat Oncol. 12(4) (2022) e253-e268. doi: 10.1016\/j.prro.2022.03.001. (Epub 2022 Mar 11. PMID: 35283342).","DOI":"10.1016\/j.prro.2022.03.001"},{"key":"10.1016\/j.radonc.2025.111107_b0025","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"10.1016\/j.radonc.2025.111107_b0030","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jclinepi.2015.06.005","article-title":"ROBIS: a new tool to assess risk of bias in systematic reviews was developed","volume":"69","author":"Whiting","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2025.111107_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3171\/jns.2007.106.1.1","article-title":"Stereotactic radiosurgery\u2014an organized neurosurgery-sanctioned definition","volume":"106","author":"Barnett","year":"2007","journal-title":"JNS"},{"key":"10.1016\/j.radonc.2025.111107_b0040","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1046\/j.1440-1673.2001.00873.x","article-title":"System validation and work practice efficiency gains of a new localization method for stereotactic radiotherapy","volume":"45","author":"Ebert","year":"2001","journal-title":"Australas Radiol"},{"key":"10.1016\/j.radonc.2025.111107_b0045","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/COC.0b013e31826e053d","article-title":"American college of radiology (ACR) and American society for radiation oncology (ASTRO) practice guideline for the performance of stereotactic radiosurgery (SRS)","volume":"36","author":"Seung","year":"2013","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0050","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/COC.0000000000000706","article-title":"ACR\u2013ASTRO practice parameter for the performance of stereotactic body radiation therapy","volume":"43","author":"Chao","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0055","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.ijrobp.2009.09.042","article-title":"American society for therapeutic radiology and oncology (ASTRO) and american college of radiology (ACR) practice guideline for the performance of stereotactic body radiation therapy","volume":"76","author":"Potters","year":"2010","journal-title":"Int. J. Radiation Oncology*Biology*Phys."},{"key":"10.1016\/j.radonc.2025.111107_b0060","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1016\/j.ijrobp.2004.07.701","article-title":"American society for therapeutic radiology and oncology and american college of radiology practice guideline for the performance of stereotactic body radiation therapy","volume":"60","author":"Potters","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0065","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/acm2.12146","article-title":"AAPM \u2010 RSS medical physics practice guideline 9.a. for SRS \u2010 SBRT","volume":"18","author":"Halvorsen","year":"2017","journal-title":"J Applied Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0070","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/1748-717X-8-158","article-title":"A multi-national report on methods for institutional credentialing for spine radiosurgery","volume":"8","author":"Gerszten","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0075","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: the report of AAPM task group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0080","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.clon.2011.01.155","article-title":"Stereotactic body radiotherapy. guidelines for commissioners, providers and clinicians: a national report","volume":"23","author":"Kirkbride","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0085","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The canadian association of radiation oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00066-020-01603-1","article-title":"Definition and quality requirements for stereotactic radiotherapy: consensus statement from the DEGRO\/DGMP working group stereotactic radiotherapy and radiosurgery","volume":"196","author":"Guckenberger","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111107_b0095","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00066-020-01583-2","article-title":"Technological quality requirements for stereotactic radiotherapy: Expert review group consensus from the DGMP working group for physics and technology in stereotactic radiotherapy","volume":"196","author":"Schmitt","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111107_b0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","article-title":"Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I non-small cell lung cancer","volume":"190","author":"Guckenberger","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111107_b0105","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1007\/s00066-014-0714-1","article-title":"Stereotactic body radiotherapy for liver tumors: principles and practical guidelines of the DEGRO working group on stereotactic radiotherapy","volume":"190","author":"Sterzing","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111107_b0110","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00066-014-0648-7","article-title":"Stereotactic radiosurgery for treatment of brain metastases: a report of the DEGRO working group on stereotactic radiotherapy","volume":"190","author":"Kocher","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.radonc.2025.111107_b0115","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/1754-9485.13618","article-title":"Guidelines for safe practice of stereotactic body (ablative) radiation therapy: RANZCR 2023 update","volume":"68","author":"Liu","year":"2024","journal-title":"J Med Imag Rad Onc"},{"key":"10.1016\/j.radonc.2025.111107_b0120","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/1754-9485.12336","article-title":"Guidelines for safe practice of stereotactic body (ablative) radiation therapy","volume":"59","author":"Foote","year":"2015","journal-title":"J Med Imag Rad Onc"},{"key":"10.1016\/j.radonc.2025.111107_b0125","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1159\/000475768","article-title":"Consensus on stereotactic body radiation therapy for small-sized hepatocellular carcinoma at the 7th Asia-Pacific primary liver cancer expert meeting","volume":"6","author":"Zeng","year":"2017","journal-title":"Liver Cancer"},{"key":"10.1016\/j.radonc.2025.111107_b0130","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107284","article-title":"Stereotactic body radiotherapy for lung oligo-metastases: systematic review and international stereotactic radiosurgery society practice guidelines","volume":"182","author":"Mayinger","year":"2023","journal-title":"Lung Cancer"},{"key":"10.1016\/j.radonc.2025.111107_b0140","article-title":"Practical considerations for the implementation of a stereotactic body radiation therapy program for oligo-metastases","volume":"6","author":"Chan","year":"2021","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0145","doi-asserted-by":"crossref","unstructured":"Report 91. Journal of the International Commission on Radiation Units and Measurements. 2014;14(2):1\u2013160.","DOI":"10.1093\/jicru\/ndx017"},{"key":"10.1016\/j.radonc.2025.111107_b0150","doi-asserted-by":"crossref","unstructured":"Prescribing, Recording, and Reporting Photon-Beam Intensity-Modulated Radiation Therapy (IMRT): Contents. JICRU. 2010 Apr;10(1):1\u20133.","DOI":"10.1093\/jicru_ndq002"},{"key":"10.1016\/j.radonc.2025.111107_b0155","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s12094-020-02540-2","article-title":"Recommended procedures and responsibilities for radiosurgery (SRS) and extracranial stereotactic body radiotherapy (SBRT): report of the SEOR in collaboration with the SEFM","volume":"23","author":"Conde-Moreno","year":"2021","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0160","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.prro.2023.08.001","article-title":"A cancer care ontario consensus-based organizational guideline for the planning and delivery of spine stereotactic body radiation therapy treatment in ontario","volume":"13","author":"Sahgal","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0165","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.ijrobp.2024.01.216","article-title":"NRG oncology and particle therapy Co-operative group patterns of practice survey and consensus recommendations on pencil-beam scanning proton stereotactic body radiation therapy and hypofractionated radiation therapy for thoracic malignancies","volume":"119","author":"Liu","year":"2024","journal-title":"Int J Radiation Oncology*Biology*Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0170","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1097\/JTO.0b013e31818b1771","article-title":"Practical considerations arising from the implementation of lung stereotactic body radiation therapy (SBRT) at a comprehensive cancer center","volume":"3","author":"Dahele","year":"2008","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0175","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejmp.2019.07.025","article-title":"A national survey on technology and quality assurance for stereotactic body radiation therapy","volume":"65","author":"Marino","year":"2019","journal-title":"Phys Med"},{"key":"10.1016\/j.radonc.2025.111107_b0180","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/j.prro.2020.02.011","article-title":"Stereotactic body radiation therapy for nonspine bone metastases: international practice patterns to guide treatment planning","volume":"10","author":"Nguyen","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2020.05.024","article-title":"Multi-institutional dosimetric delivery assessment of intracranial stereotactic radiosurgery on different treatment platforms","volume":"147","author":"Dimitriadis","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.radonc.2019.11.001","article-title":"Variation in current prescription practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer: Recommendations for prescribing and recording according to the ACROP guideline and ICRU report 91","volume":"142","author":"De Jong","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2020.10.039","article-title":"High dose per fraction, hypofractionated treatment effects in the clinic (HyTEC): an overview","volume":"110","author":"Grimm","year":"2021","journal-title":"Int Radiation Oncology*Biology*Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.radonc.2022.10.005","article-title":"Recommendations for radiation therapy in oligometastatic prostate cancer: an ESTRO-ACROP Delphi consensus","volume":"176","author":"Zilli","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.radonc.2022.06.002","article-title":"ESTRO ACROP guidelines for external beam radiotherapy of patients with complicated bone metastases","volume":"173","author":"Oldenburger","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0210","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.prro.2022.09.004","article-title":"Quality and safety considerations in image guided radiation therapy: an ASTRO safety white paper update","volume":"13","author":"Qi","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0215","first-page":"5301","article-title":"European organisation for research and treatment of cancer recommendations for planning and delivery of high-dose","volume":"28","author":"De Ruysscher","year":"2010","journal-title":"High-Precision Radiotherapy for Lung Cancer JCO"},{"key":"10.1016\/j.radonc.2025.111107_b0220","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/fon.16.2","article-title":"Consensus statement from the international radiosurgery oncology consortium for kidney for primary renal cell carcinoma","volume":"12","author":"Siva","year":"2016","journal-title":"Future Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0225","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1002\/mp.12227","article-title":"Motion management strategies and technical issues associated with stereotactic body radiotherapy of thoracic and upper abdominal tumors: a review from NRG oncology","volume":"44","author":"Brandner","year":"2017","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0230","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.prro.2022.10.013","article-title":"ISRS technical guidelines for stereotactic radiosurgery: treatment of small brain metastases (\u22641 cm in diameter)","volume":"13","author":"Grishchuk","year":"2023","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0235","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1016\/j.prro.2019.07.018","article-title":"Australasian gastrointestinal trials group (AGITG) and trans-tasman radiation oncology Group (TROG) guidelines for pancreatic stereotactic body radiation therapy (SBRT)","volume":"10","author":"Oar","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0240","first-page":"33","article-title":"Stereotactic body radiation therapy for spine and non-spine bone metastases. GETUG (french society of urological radiation oncologists) recommendations using a national two-round modified Delphi survey. Clinical and Translational","volume":"37","author":"Vilotte","year":"2022","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109969","article-title":"Efficacy and safety of SBRT for spine metastases: a systematic review and meta-analysis for preparation of an ESTRO practice guideline","volume":"190","author":"Guninski","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0250","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1748-717X-4-1","article-title":"Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the Quality Assurance Working Party of the randomised phase III ROSEL study","volume":"4","author":"Hurkmans","year":"2009","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0255","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.prro.2019.11.002","article-title":"A Cancer care ontario organizational guideline for the delivery of stereotactic radiosurgery for brain metastasis in ontario","volume":"10","author":"Sahgal","year":"2020","journal-title":"Canada Practical Radiation Oncology"},{"key":"10.1016\/j.radonc.2025.111107_b0260","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/153303461000900307","article-title":"Intracranial radiosurgery in the netherlands. A planning comparison of available systems with regard to physical aspects and workload","volume":"9","author":"Schoonbeek","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.radonc.2025.111107_b0265","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1016\/j.prro.2016.05.004","article-title":"Rationale of technical requirements for NRG-BR001: the first NCI-sponsored trial of SBRT for the treatment of multiple metastases","volume":"6","author":"Al-Hallaq","year":"2016","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0270","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12094-021-02695-6","article-title":"SEOR SBRT-SG stereotactic body radiation therapy consensus guidelines for non-spine bone metastasis","volume":"24","author":"Lopez-Campos","year":"2022","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0275","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ijrobp.2009.11.055","article-title":"Prescription dose guideline based on physical criterion for multiple metastatic brain tumors treated with stereotactic radiosurgery","volume":"78","author":"Sahgal","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110466","article-title":"Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: an interim analysis of the E2-RADIatE OligoCare cohort","volume":"199","author":"Alongi","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2025.111107_b0285","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/jnci\/djac015","article-title":"Randomized trial of first-line tyrosine kinase inhibitor with or without radiotherapy for synchronous oligometastatic EGFR-mutated non-small cell lung cancer","volume":"115","author":"Wang","year":"2023","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2025.111107_b0290","doi-asserted-by":"crossref","unstructured":"Lightstone AW, Benedict SH, Bova FJ, Solberg TD, Stern RL. Intracranial stereotactic positioning systems: Report of the American Association of Physicists in Medicine Radiation Therapy Committee Task Group No. 68: AAPM Task Group 68 Report. Med Phys. 2005 Jun 23;32(7Part1):2380\u201398.","DOI":"10.1118\/1.1945347"},{"key":"10.1016\/j.radonc.2025.111107_b0295","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1016\/j.ijrobp.2007.04.098","article-title":"Linear accelerator and gamma knife\u2013based stereotactic cranial radiosurgery: challenges and successes of existing quality assurance guidelines and paradigms","volume":"71","author":"Goetsch","year":"2008","journal-title":"Int J Radiation Oncology*Biology*Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0300","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/acm2.12406","article-title":"COMP report: CPQR technical quality control guidelines for Gamma Knife radiosurgery","volume":"19","author":"Berndt","year":"2018","journal-title":"J Applied Clin Med Phys"},{"key":"10.1016\/j.radonc.2025.111107_b0305","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1200\/JCO.22.00333","article-title":"Radiation therapy for brain metastases: ASCO guideline endorsement of ASTRO guideline","volume":"40","author":"Schiff","year":"2022","journal-title":"JCO"},{"key":"10.1016\/j.radonc.2025.111107_b0310","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.prro.2023.08.011","article-title":"Stereotactic body radiation therapy: a radiosurgery society guide to the treatment of localized prostate cancer illustrated by challenging cases","volume":"14","author":"Ma","year":"2024","journal-title":"Pract Radiat Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814025046110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T20:04:08Z","timestamp":1759521848000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814025046110"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":62,"alternative-id":["S0167814025046110"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111107","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definition and requirements for stereotactic radiotherapy: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.111107","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"111107"}}